SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000929638-22-000273
Filing Date
2022-02-08
Accepted
2022-02-08 17:00:36
Documents
1
Group Members
MERCK B.V.MERCK VENTURES B.V.

Document Format Files

Seq Description Document Type Size
1 sched13ga.htm SC 13G/A 77906
  Complete submission text file 0000929638-22-000273.txt   79583
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89626 | Film No.: 22602420
SIC: 2834 Pharmaceutical Preparations

Mailing Address FRANKFURTER STR. 250 DARMSTADT 2M 64293
Business Address FRANKFURTER STR. 250 DARMSTADT 2M 64293 004961517245950
Merck KGaA (Filed by) CIK: 0001764133 (see all company filings)

IRS No.: 980233737 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G/A